MarketCapTrends
CLDX

Celldex Therapeutics Inc. (CLDX)

NASDAQ · Healthcare

Celldex Therapeutics Inc. annual/quarterly cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Celldex Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 28.9M, a 1.82% increase year-over-year.
  • Celldex Therapeutics Inc. cash on hand for 2025 were 28.9M, a 1.82% increase from 2024.
  • Celldex Therapeutics Inc. cash on hand for 2024 were 28.4M, a 18.55% decrease from 2023.
  • Celldex Therapeutics Inc. cash on hand for 2023 were 34.8M, a 18.30% increase from 2022.
  • Celldex Therapeutics Inc. cash on hand for 2022 were 29.4M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Celldex Therapeutics Inc. Annual Cash on Hand (Millions of US $)
2025$29
2024$28
2023$35
2022$29
2021$39
2020$44
2019$11
2018$24
2017$40
2016$42
2015$72
2014$28
2013$169
2012$25
2011$12
Celldex Therapeutics Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$29
2024-12-31$28
2023-12-31$35
2022-12-31$29
2021-12-31$39
2020-12-31$44
2019-12-31$11
2018-12-31$24
2017-12-31$40
2016-12-31$42
2015-12-31$72
2014-12-31$28
2013-12-31$169
2012-12-31$25
2011-12-31$12
2010-12-31$21

Celldex Therapeutics Inc. Cash on Hand — FAQ

Celldex Therapeutics Inc. (CLDX) cash on hand over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CLDX's cash on hand history?

The chart and table above show Celldex Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.